Phosphodiesterase-5 Inhibitor Use in Robot Assisted Radical Prostatectomy Patients Is Associated with Reduced Risk of Death: A Propensity Score Matched Analysis of 1,058 Patients

Overview of attention for article published in The World Journal of Men's Health, January 2023

Altmetric Badge

Mentioned by

So far, Altmetric has seen 3 news stories from 3 outlets.

Phosphodiesterase-5 inhibitor (PDE5i) use after robotic prostate cancer surgery is associated with decreased death risk…

Phosphodiesterase-5 inhibitor (PDE5i) use after robotic prostate cancer surgery is associated with a decreased risk of death…

Phosphodiesterase-5 inhibitor (PDE5i) use after robotic prostate cancer surgery is associated with decreased death risk…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.